Business Case Studies, Value Chain Analysis Case Study, Novartis,Generic Drug Business

print page
Tell A Friend
Bookmark
 

Case Categories

Value Chain Analysis Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Novartis' Generic Drug Business: The New Growth Driver

Publication Year : 2005

Authors: Shalini, Sumit Kumar Chaudhuri

Industry: Health Care

Region:Switzerland

Case Code: VCA0011

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study
OR





Abstract:
In 2003, to lay more emphasis on its generics business, Novartis rebranded its entire generics product lines under the Sandoz brand, the brand that had merged with Ciba-Geigy to form Novartis in 1996. In February 2005, Novartis acquired Germany-based generic drugs company, Hexal, and its affiliate, Eon Labs, for enhancing its capability to grab a 10% market share in the US$100 billion global generics market by 2010

Pedagogical Objectives:

  • To highlight the growth strategies of Novartis in the generics business
  • To discuss the strategies adopted by Novartis to face the twin challenges of low prices and high competition in the global generic drug industry.

Keywords : Novartis; Sandoz; Generics; Strategy; Branded drugs; Patent; Generics market; Growth Strategies Case Study; Pharmaceutical industry; USA; Germany; Growth; Eon; Hexal; Sabex

Contents:

  • The Generic Drug Business of Novartis
  • Novartis' Strategy to be a Leader in Generics Market
  • The Payoffs

Recently Bought Case Studies

    Recently Bought Case Studies
advertisement

    Executive Interviews

  • David ConklinDavid Conklin

    David Conklin, is a professor at the Richard Ivey School of Business
    Speaks on Government and Business
  • Lord Meghnad DesaiLord Meghnad Desai

    Lord Meghnad Desai, is an Indian-born British economist and Labor politician
    Speaks on Government and Business
  • Vijay GovindarajanVijay Govindarajan

    Vijay Govindarajan, is widely regarded as one of the world’s leading experts on strategy and innovation
    Speaks on Reverse Innovation
  • View All Executive Interviews»






Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501 504, Andhra Pradesh, INDIA.
Mob: +91- 9640901313, Phone: +91 - 08417 - 236672, Fax : + 91 - 08417 - 236674
E-mail: casehelpdesk@ibsindia.org

©2003-2010 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap